9. R. Rosedale, “Life, Death, Food and the Disease of Aging,” presented at the American Academy of Anti-Aging in Orlando, Florida, 2011.
10. С. Е. Forsythe et al., “Comparison of Low Fat and Low Carbohydrate Diets on Circulation Fatty Acid Composition and Markers of Inflammation” Lipids, 43, no. 1 ("2008): 65–77, DOI: 10.1007/sll745-007-3132-7.
11. S. McKenzie, “Yoshinori Ohsumi Wins Nobel Prize for Medical Research on Cells,” CNN.com, October 3, 2016, http://www.cnn.com/2016/10/03/health/ nobel-prize-201 б-physiology-medicine-yoshinori-ohsumi/, accessed 12/2/16.
12. K. J. Bough et al., “Mitochondrial Biogenesis in the Anticonvulsant Mechanism of the Ketogenic Diet,” Annals of Neurology, 60 (2006): 223–235, DOI: 10.1002/ana.20899.
13. P. J. Cox, K. Clarke, “Acute Nutritional Ketosis: Implications for Exercise Performance and Metabolism,” Extreme Physiology & Medicine, 3 (2014): 1, DOI: 10.1186/2046-7648-3-17.
14. О. E. Owen et al., “Liver and Kidney Metabolism During Prolonged Starvation,” Journal of Clinical Investigation, 48, no. 3 (1969): 574–583.
15. M. Akram, “A Focused Review of the Role of Ketone Bodies in Health and Disease,” Journal of Medicinal Food, 16, no. 11 (November 2013): 965–967, DOI: 10.1089/jmf.2012.2592.
16. Там же.
17. Phinney and Volek, The Art and Science of Low-Carbohydrate Living, 10.
18. Interview with Jeff Volek, Ph.D., http://articles.mercola.com/sites/articles/ar-chive/2016/01/31 /high-fat-low-carb-diet-benefits.aspx, accessed 12/2/16.
19. J. C. Newman and E. Verdin, “(3-hydroxybutyrate: Much More Than a Metabolite,” Diabetes Research and Clinical Practice, 106, no. 2 (2014): 173–181, DOI: 10.1016/j. diabres.2014.08.009.
20. A. Paoli et al., “Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases,” BioMed Research International, 2014 (2014), DOI: 10.1155/2014/474296.
21. M. A. McNally and A. L. Hartman, “Ketone Bodies in Epilepsy,” Journal of Neurochemistry, 121, no. 1 (2012): 28–35, DOI: 10.1111/j.l471-4159.2012.07670.x.
22. J. Moore, Keto Clarity (Victory Belt Publishing, 2014), 58.
23. A. J. Brown, “Low-Carb Diets, Fasting and Euphoria: Is There a Link between Ketosis and Gamma-hydroxybutyrate (GHB)?” Medical Hypotheses, 68, no. 2 (2007): 268–271, DOI: 10.1016/j.mehy.2006.07.043.
Глава 3
1. E. L. Knight et al., “The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency,” Annals of Internal Medicine, 138. no. 6 (2003): 460–467, DOI: 10.7326/0003-4819-138-6-200303180-00009.
2. M. I. Frisard et al., “Effect of 6-Month Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals: A Randomized Controlled Trial,” http://jamanetwork.com/journals/jama/fullarti-cle/1108368.
3. M. E. Levine et al., “Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population,” Cell Metabolism, 19, no. 3 (2014): 407–417, DOI: 10.1016/j. cmet.2014.02.006.
4. J. Guevara-Aguirre et al., “Growth Hormone Receptor Deficiency Is Associated With a Major Reduction in Pro-aging Signaling, Cancer and Diabetes in Humans,” Science Translational Medicine, 3, no. 70 (2011): 70, DOI: 10.1126/ scitranslmed.3001845.
5. S. I. A. Apelo and D. W. Lamming, “Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island,” Journal of Gerontology, 71, no. 7 (2016): 841–849, DOI: 10.1093/gerona/glw090.
6. S. M. Solon-Biet et al., “The Ratio of Macronutrients, Not Caloric Intake, Dictates Cardiometabolic Health, Aging, and Longevity in Ad Libi-tum-Fed Mice,” Cell Metabolism, 19, no. 3 (2014): 418–430, DOI: 10.1016/j. cmet.2014.02.009.
Глава 4
1. “Ferritin: The Test,” American Association for Clinical Chemistry, https://labtest-sonline.org/understanding/analytes/ferritin/tab/test/, accessed May 9, 2016.
2. E. D. Weinberg, “The Hazards of Iron Loading,” Metallomics, 2, no. 11 (November, 2010): 732–740, DOI: 10.1039/c0mt00023j.
3. M. D. Beaton and P. C. Adams, “Treatment of Hyperferritinemia,” Annals of Hepatology, 11, no. 3 (2012): 294–300, PMID: 22481446.
4. G. Ortiz-Estrada et al., “Iron-Saturated Lactoferrin and Pathogenic Protozoa: Could This Protein Be an Iron Source for Their Parasitic Style of Life?” Future Microbiology, 7, no. 1 (2012): 149–164, DOI: 10.2217/fmb. 11.140.
5. D. }. Fleming et al., “Dietary Factors Associated with the Risk of High Iron Stores in the Elderly Framingham Heart Study Cohort,” American Journal of Clinical Nutrition, 76, no. 6 (2002): 1375–1384, PMID: 12450906.
6. T. Iwasaki et al, “Serum Ferritin Is Associated with Visceral Fat Area and Subcutaneous Fat Area,” Diabetes Care, 28, no. 10 (2005): 2486–2491, PMID: 16186284.
7. S. К. Park et al., “Association between Serum Ferritin Levels and the Incidence of Obesity in Korean Men: A Prospective Cohort Study” Endocrine Journal, 61, no. 3 (2014): 215–224, DOI: 10.1507/endocrj.EJ13-0173.
8. Там же.
9. J. M. Fernandez-Real et al., “Serum Ferritin as a Component of the Insulin Resistance Syndrome,” Diabetes Care, 21, no. 1 (1998): 62–68, DOI: 10.2337/dia-care.21.1.62.
10. J. Montonen et al., “Body Iron Stores and Risk of Type 2 Diabetes: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study,” Diabetologia, 55, no. 10 (2012): 2613–2621, DOI: 10.1007/s00125-012-2633-y.
11. J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart, “Iron Stores, Blood Donation, and Insulin Sensitivity and Secretion,” Clinical Chemistry, 51, no. 7 (June 2005): 1201–1205, DOI: 10.1373/clinchem.2004.046847.
12. B. J. Van Lenten et al., “Lipid-Induced Changes in Intracellular Iron Homeostasis in Vitro and in Vivo,” Journal of Clinical Investigation, 95, no. 5 (1995): 2104–2110, DOI: 10.1172/JCI117898.
13. N. Stadler, R. A. Lindner, and M. J. Davies, “Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper,” Arteriosclerosis, Thrombosis, and Vascular Biology, 24 (2004): 949–954, DOI: 10.1161/01. ATV.0000124892.90999.cb.
14. W. B. Kannel et al., “Menopause and Risk of Cardiovascular Disease: The Framingham Study,” Annals of Internal Medicine, 85 (1976): 447–452, DOI: 10.7326/0003-4819-85-4-447.
15. M. A. Lovell et al., “Copper, Iron and Zinc in Alzheimer’s Disease Senile Plaques,” Journal of the Neurological Sciences, 158, no. 1 (June 11, 1998): 47–52, DOI: 10.1016/S0022-510X(98)00092-6.
